2022 Could be a Banner Year for Biotech Stocks as per top managers (SPRC, HOTH, NLSP, PSTV, IMMX, GNPX, NRBO)

2021 was a year to be easily forgotten for biotech stocks. The S&P 500 climbed 26.9%. However, SPDR S&P Biotech exchange-traded fund dropped 20.5%. Looks like 2022 will be “THE” year for biotech sector. In a recent note from Piper Sandler analyst Christopher Raymond and his colleagues, Raymond said that he recommended “selective buying” of […]

Breaking: Stocks Running on Virus Testing News (TMO, ALST, LH)

Yesterday was a rough day for risk assets after Germany announced an Easter lockdown to avoid a new acceleration in Covid-19 cases and deaths. The measures are a response to recent worrying signs of trouble in the EU in terms of vaccine distribution. New variants and unexpected case increases have everyone back on alert. In […]

Bitcoin Roller Coaster Continues, Mimicking Path of Cannabis

A few years ago, Bitcoin was an afterthought (or a non-thought) to most on Wall Street.  It was so poorly understood that plenty of traders couldn’t even tell you the difference between Bitcoin and blockchain, the digital ledger technology serving as the heartbeat of cryptocurrencies. Most analysts were bearish, deriding crypto in saying there was […]

Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) Meets Q3 2017 Revenue

Himax Technologies, Inc. (ADR)(NASDAQ:HIMX) issued its financial report for the third quarter closed September 30, 2017. The firm’s Q3 2017 revenue and GAAP earnings/diluted ADS was recorded at high end of projection while non-GAAP earnings/diluted ADS and gross margin both surpassed the projection. The details Jordan Wu, the CEO and President of Himax, expressed that […]

Geron Corporation (NASDAQ:GERN) Reports Fast Track Designation For Imetelstat Targeting Lower Risk Myelodysplastic Syndromes

Geron Corporation (NASDAQ:GERN) reported that the U.S. FDA has granted Fast Track designation to imetelstat for the prospective treatment of adult people with transfusion-dependent anemia following low or Intermediate-1 risk MDS who are non-del and who are resistant or refractory to treatment with an ESA. Imetelstat marks as a telomerase inhibitor initially advanced by Geron […]

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) Showcases Results From trial Examining Patient and Physician Experiences And Perceptions With IBS-C

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) reported new findings showcasing the frustration of patients suffering from IBS-C and the viewpoint of healthcare providers who cure these patients. The web questionnaire, intended to advance a better understanding of the attitudes and experiences associated with IBS-C, disclosed numerous patients experienced lost productivity and stress when managing this problem. HCPs […]

Delcath Systems, Inc. (OTCMKTS:DCTH) Releases Letter To Shareholders

Delcath Systems, Inc. (OTCMKTS:DCTH) reported that Jennifer K. Simpson, Ph.D., the CEO and President has released a Letter to Stockholders offering a business update and motive behind the firm’s recent measures to preserve capital access. It explained the steps that the company has been taking to restore its access to capital so that it can […]

What Is The Buzz Surrounding Zymeworks Inc (NYSE:ZYME)?

Zymeworks Inc (NYSE:ZYME) reported that Merck, also termed as MSD outside the United States and Canada has released formal notification of their plans to develop a bispecific drug candidate into preclinical advancement. The drug candidate was advanced by Merck, through a subsidiary, together with Zymeworks utilizing Zymeworks’ proprietary EFECT™ and Azymetric™ platforms as part of […]

The Preclinical Influenza Nanoparticle Study By Novavax, Inc (NASDAQ:NVAX) Published In Vaccine

The stock of Novavax, Inc (NASDAQ:NVAX) closed at $1.06 maintaining the same standing in yesterday’s trading session. This provider has today made an announcement regarding the publication of data from a preclinical study of its nanoparticle influenza vaccine candidate with its proprietary Matrix-M(TM) adjuvant (NanoFlu(TM)) in the journal Vaccine. It is directing a lot of […]

Cerus Corporation (NASDAQ:CERS) Announces Amended Growth Capital Deal

Cerus Corporation (NASDAQ:CERS) reported that it has finalized a $40 million amended growth capital agreement with Oxford Finance LLC, a firm that offers senior debt to healthcare services and life sciences firms globally. Under the amended facility, the company obtained an immediate loan of $30 million at closing on July 2017 and has the alternative […]

Inovio Pharmaceuticals Inc (NASDAQ:INO) Is Now Offering Common Stock To the Public For The Acquire

The current developments have shown that Inovio Pharmaceuticals Inc (NASDAQ:INO) has finally accepted to sell its shares to the public after a very long period of time of anticipation from the public. According to different sources, Inovio has already announced the pricing of underwritten public offering of 12,500,000 shares of its common stocks will be […]

MannKind Corporation (NASDAQ:MNKD) Draws Remaining Funds under Mann Group Loan Arrangement

MannKind Corporation (NASDAQ:MNKD) has announced serving Mann Group LLC with a funding request notification in regards to the terms of the Mann Group Loan Arrangement to draw the outstanding $30.1 million of the agreement. After receiving the funding, MannKind will use the $10.6 million proceeds for capital and pay off its interest accrued under the […]

Biostage Inc (NASDAQ:BSTG) Unveils Positive Preclinical Data Of Cellspan™ Esophageal Implant As It Looks Forward To Generate More Revenues

The International Society for Stem Cell Research (ISSCR) 2017 Annual Meeting that was held on June 14-17, 2017 in Boston, MA was to determine a lot in the future of the medical world. One of the companies that made presentations was Biostage Inc (NASDAQ:BSTG). Today, the company has got some great news for all the concerned […]